G Vallancien. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adrenergic alpha-Antagonists/therapeutic useErectile Dysfunction/epidemiologyHumansMaleProstatic Hyperplasia/complicationsProstatic Hyperplasia/drug therapyQuality of LifeTime Factors
Substances: See more » Adrenergic alpha-Antagonists
Year: 1999 PMID: 10565731 DOI: 10.1016/s0090-4295(99)00340-4
Source DB: PubMed Journal: Urology ISSN: 0090-4295 Impact factor: 2.649